Form 8-K - Current report:
SEC Accession No. 0001493152-21-006721
Filing Date
2021-03-24
Accepted
2021-03-24 16:28:50
Documents
4
Period of Report
2021-03-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 36958
2 ex1-1.htm EX-1.1 254321
3 ex4-1.htm EX-4.1 129917
4 ex5-1.htm EX-5.1 11617
  Complete submission text file 0001493152-21-006721.txt   434101
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-37492 | Film No.: 21768502
SIC: 2834 Pharmaceutical Preparations